CTLA4 and cancer: ICI treatment is a common therapeutic approach in cancer, which mainly includes anti-programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) and anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) [93].